Used primarily as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its fluorinated cyclobutyl structure enhances metabolic stability and binding selectivity, making it valuable in optimizing drug candidates for improved pharmacokinetics. It is also employed in the preparation of bioactive molecules targeting inflammatory and neurological disorders due to its ability to cross biological membranes effectively.